Login to Your Account

U.S. Patent Disclosures

Thursday, July 28, 2011
Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No. 7,964,563, titled "Oligodendrocyte Precursor Cell Proliferation Regulated By Prolactin," which covers the firm's use of Prolactin for multiple sclerosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription